LD-2 disclosure · 3rd Quarter - Termination
Q THERAPEUTICS, INC.
Client
- Name
- Q THERAPEUTICS, INC.
- Description
- BIOPHARMACEUTICAL COMPANY
- Location
- Utah · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury; Get congressional support for company's application for tax credit or grant available under I.R.C. Sec. 48D.
LobbyistsMICHAEL WERNER · SANTIAGO VACA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)
Defense
Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury.
LobbyistsMICHAEL WERNER · SANTIAGO VACA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)
Medical/Disease Research/Clinical Labs
Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury.
LobbyistsMICHAEL WERNER · SANTIAGO VACA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)